Allergy and Immunology · Roseville, CA
NPI
1649426602
Since 2008
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8735 Sierra College Blvd Ste 200
Roseville, CA, 95661
Phone (916) 771-2531
Groups this clinician bills Medicare through
Medicare paid, 2024
$892K
56,058 services
Medicare patients, 2024
365
Average age 73
Drug cost, 2024
$1.5M
1,222 prescriptions
Company payments, 2025
$3,435
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chiraag S Patel was code 95004 (test - miscellaneous), 18,196 times for 133 patients. In total Chiraag S Patel billed 56,058 services in 37 codes, and Medicare paid $892K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 18,196 | 133 | $3.03 | $55K |
| J2357 Injection, omalizumab, 5 mg | Office | 6,600 | 12 | $29.73 | $196K |
| 95024 Test - Miscellaneous | Office | 6,427 | 109 | $6.94 | $45K |
| 95165 Treatment - Miscellaneous | Office | 6,334 | 142 | $11.95 | $76K |
| 95044 Test - Miscellaneous | Office | 1,707 | 22 | $3.98 | $6,790 |
| 95117 Treatment - Miscellaneous | Office | 1,529 | 133 | $9.92 | $15K |
| 99214 Office E&M - Established | Office | 607 | 297 | $102.29 | $62K |
| 95180 Treatment - Miscellaneous | Office | 493 | 27 | $115.99 | $57K |
| 94010 Pulmonary Function Testing | Office | 423 | 194 | $21.84 | $9,240 |
| 96401 Chemotherapy Administration | Office | 349 | 37 | $61.09 | $21K |
| 95012 Pulmonary | Office | 309 | 181 | $15.33 | $4,738 |
| 96372 Injection Administration | Office | 162 | 26 | $11.18 | $1,811 |
| 99204 Office E&M - New | Office | 112 | 112 | $136.32 | $15K |
| 99458 E&M - Miscellaneous | Office | 104 | 13 | $32.78 | $3,409 |
| 99457 E&M - Miscellaneous | Office | 101 | 15 | $41.50 | $4,192 |
By year: 2022 $853K for 53,452 services; 2023 $868K for 58,466 services; 2024 $892K for 56,058 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chiraag S Patel prescribed most often to Medicare patients was Montelukast Sodium, with 292 prescriptions and refills. In total Chiraag S Patel wrote 1,222 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 292 | 840 | 128 | $4,022 |
| Ipratropium Bromide Generic | 103 | 167 | 45 | $6,459 |
| Epinephrine Generic | 93 | 97 | 79 | $21K |
| Symbicort Budesonide/Formoterol Fumarate | 59 | 103 | 37 | $24K |
| Xolair Omalizumab | 53 | 53 | Under 11 | $273K |
| Breyna Budesonide/Formoterol Fumarate | 53 | 113 | 22 | $14K |
| Prednisone Generic | 51 | 59 | 44 | $250 |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 48 | 50 | Under 11 | $450K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 40 | 74 | 15 | $44K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 36 | 59 | 13 | $36K |
| Arnuity Ellipta Fluticasone Furoate | 31 | 69 | 13 | $15K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 30 | 38 | 21 | $5,371 |
| Pantoprazole Sodium Generic | 25 | 71 | 14 | $462 |
| Nucala Mepolizumab | 24 | 24 | Under 11 | $81K |
| Mometasone Furoate Generic | 20 | 32 | Under 11 | $2,708 |
Brand drugs: 508 claims; generic drugs: 714 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chiraag S Patel $3,435 ($3,435 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,144.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 42 | $1,144 |
| CSL Behring CSL.AX | 26 | $619 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 15 | $323 |
| Genzyme Corporation SNY | 17 | $271 |
| Amgen Inc. AMGN | 11 | $223 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $158 |
| GlaxoSmithKline, LLC. GSK | 4 | $88.84 |
| Incyte Corporation INCY | 4 | $83.62 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $82.84 |
| Optinose US, Inc. | 4 | $79.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.